Mathew Coleman

Dr.

Accepting PhD Students

PhD projects

Mathew Coleman's research focusses on the role of protein hydroxylation in the cell biology of tumour cells. He has attracted highly competitive funding support from Cancer Research UK, the MRC, BBSRC and Glaxo Smith Kline. His work on protein hydroxylation has led to patents, and highly cited articles and high impact research and review publications including most recently in Nature, Nature Chemical Biology, PNAS and Molecular Cell. The Tumour Oxygenase Group always welcomes applications from talented and enthusiastic doctoral researchers to study the role of protein hydroxylation in cancer.

20012021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Peter J Ratcliffe

  • Nuffield Department of Clinical Medicine
  • The Francis Crick Institute

External person

Christopher J Schofield

  • University of Oxford

External person

Atsushi Yamamoto

  • Nuffield Department of Clinical Medicine

External person

Michael A McDonough

  • University of Oxford

External person

Mark Bix

  • Chiba University

External person

Ming Yang

  • Children's Hospital of Nanjing Medical University

External person

Meenu R Pillai

  • St Jude Children’s Research Hospital

External person

Daniel Biggs

  • University of Oxford

External person

Wei Ge

  • University of Oxford

External person

Chris W Pugh

  • Nuffield Department of Clinical Medicine

External person

Anthony Tumber

  • University of Oxford Medical Sciences Division
  • University of Oxford

External person

Antonello Mai

  • University of Rome La Sapienza

External person

Daniela Passeri

  • TES Pharma S.r.l.

External person

Alessia Ciogli

  • University of Rome La Sapienza

External person

Dörthe M. Katschinski

  • University of Göttingen
  • German Centre for Cardiovascular Research (DZHK)

External person

rachelle singleton

  • University of Oxford

External person

Julie Adam

  • University of Oxford

External person

Radosław P. Nowak

  • University of Oxford Medical Sciences Division

External person

P Liu-Yi

  • University of Oxford

External person

Toshinori Nakayama

  • Chiba University

External person

Catrine Johansson

  • University of Oxford Medical Sciences Division
  • University of Oxford

External person

Aline Jatho

  • University of Göttingen

External person

Maureen A. McGargill

  • St Jude Children’s Research Hospital

External person

Francesca Romana Pellegrini

  • Sapienza University of Rome

External person

Mohammad Salik Zeya Ansari

  • Sapienza University of Rome

External person

pablo wappner

  • Leloir Institute Foundation

External person

Christoph Loenarz

  • University of Oxford

External person

Tokiyoshi Ayabe

  • Hokkaido University

External person

Fischer R

  • University of Oxford

External person

Akane Kawamura

  • Newcastle University

External person

Kenji Ishiwata

  • Jikei University School of Medicine

External person

Klemensas Simelis

  • University of Oxford

External person

Ben Davies

  • University of Oxford

External person

Katja Brechtel-Curth

  • University of Göttingen

External person

Donatella Del Bufalo

  • IRCCS-Regina Elena National Cancer Institute

External person

Gail M Preston

  • University of Oxford

External person

Dante Rotili

  • University of Rome La Sapienza

External person

Charlotte E Coles

  • University of Cambridge

External person

Patrick Pollard

  • University of Oxford

External person

Eidarus Salah

  • University of Oxford

External person

F Formenti

  • University of Oxford

External person

Belgacem Mihi

  • Chiba University

External person

Daniela Trisciuoglio

  • Sapienza University of Rome

External person

David B. Finkelstein

  • St Jude Children’s Research Hospital

External person

Emily Flashman

  • University of Oxford

External person

Alex Wolf

  • University of Oxford

External person

Ana M. Vergel Leon

  • University of Göttingen

External person

Kiminori Nakamura

  • Hokkaido University

External person

Rino Ragno

  • University of Rome La Sapienza

External person

Aviv Regev

  • Massachusetts Institute of Technology
  • Broad Institute

External person

A Thalhammer

  • University of Oxford

External person

Roberto Pellicciari

  • TES Pharma S.r.l.

External person

Naoya Sakuragi

  • Hokkaido University

External person

Lorenzo Antonini

  • University of Rome La Sapienza

External person

Benedikt Kessler

  • University of Oxford

External person

Bart Ghesquiere

  • Vesalius Research Center
  • VIB
  • Catholic University of Leuven

External person

Nicola Mautone

  • University of Rome La Sapienza

External person

Udo Oppermann

  • University of Oxford Medical Sciences Division

External person

Manuela Sabatino

  • University of Rome La Sapienza

External person

Rok Sekirnik

  • University of Oxford

External person